Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Burning Rock Biotech (BNR) Equity Average: 2020

  • Burning Rock Biotech's Equity Average was N/A to $372.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $372.0 million, marking a year-over-year change of. This contributed to the annual value of $93.9 million for FY2024, which is 32.00% down from last year.
  • Per Burning Rock Biotech's latest filing, its Equity Average stood at $372.0 million for Q4 2020, which was down 1.16% from $376.4 million recorded in Q3 2020.
  • In the past 5 years, Burning Rock Biotech's Equity Average ranged from a high of $376.4 million in Q3 2020 and a low of $372.0 million during Q4 2020.
  • Its 1-year average for Equity Average is $374.2 million, with a median of $374.2 million in 2020.